2013
DOI: 10.1002/embr.201337294
|View full text |Cite
|
Sign up to set email alerts
|

Cytosolic cleaved PINK 1 represses P arkin translocation to mitochondria and mitophagy

Abstract: PINK1 is a mitochondrial kinase proposed to have a role in the pathogenesis of Parkinson's disease through the regulation of mitophagy. Here, we show that the PINK1 main cleavage product, PINK1 52, after being generated inside mitochondria, can exit these organelles and localize to the cytosol, where it is not only destined for degradation by the proteasome but binds to Parkin. The interaction of cytosolic PINK1 with Parkin represses Parkin translocation to the mitochondria and subsequent mitophagy. Our work t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
86
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(93 citation statements)
references
References 29 publications
(76 reference statements)
3
86
3
Order By: Relevance
“…More recently, recruitment of PARKIN by PINK1 to mitochondria has also been observed in primary neurons in a reactive oxygen speciesdependent manner (12,23). Interestingly, processed cytosolic PINK1 may also interact with cytosolic PARKIN, limiting its translocation to the mitochondria and mitophagy (15). Likewise, in the presence of MG-132, an inhibitor of the proteasome, the level of processed cytosolic PINK1 is increased significantly (24), indicating that turnover of PINK1 is through the proteasomal pathway.…”
Section: Parkinson Disease (Pd)mentioning
confidence: 92%
See 1 more Smart Citation
“…More recently, recruitment of PARKIN by PINK1 to mitochondria has also been observed in primary neurons in a reactive oxygen speciesdependent manner (12,23). Interestingly, processed cytosolic PINK1 may also interact with cytosolic PARKIN, limiting its translocation to the mitochondria and mitophagy (15). Likewise, in the presence of MG-132, an inhibitor of the proteasome, the level of processed cytosolic PINK1 is increased significantly (24), indicating that turnover of PINK1 is through the proteasomal pathway.…”
Section: Parkinson Disease (Pd)mentioning
confidence: 92%
“…However, PINK1-deficient cells display altered calcium homeostasis at the mitochondria as well as altered mitochondrial function (14). Processed PINK1 at the inner mitochondrial membrane has also been proposed to be shuttled to the cytosol, where it is degraded by the proteasome (15). However, under conditions of mitochondrial stress such as treatment with the mitochondrial uncoupler carbonyl cyanide p-chlorophenylhydrazone (CCCP) or with the complex I inhibitor 1-methyl-4-phenylpyridinium (MPP ϩ ), PINK1 can also regulate mitophagy in a PARKIN-dependent fashion (12, 16 -19).…”
Section: Parkinson Disease (Pd)mentioning
confidence: 99%
“…Accumulated Pink1 undergoes dimerization and intermolecular autophosphorylation at Ser228 and Ser402 thereby activating itself, leading to downstream phosphorylation events including Parkin recruitment to mitochondria (Okatsu et al, 2012. There is also a Parkin-binding role attributed to the 53kDa truncated fragment of Pink1 (Fedorowicz et al, 2014). It is known that this fragment can be stabilized via K63-linked ubiquitylation by TRAF6 (Lim et al, 2015) which might contribute to the recruitment of Parkin to mitochondria.…”
Section: Pink1 -A Major Sensor Of Mitochondrial Qualitymentioning
confidence: 99%
“…PINK1 binds to phosphoglycerate mutase family member 5 (PGAM5) in the inner mitochondrial membrane (Lu et al, 2014a) but, upon cleavage, translocates to the cytosol for proteasomal degradation (Fedorowicz et al, 2014;Yamano and Youle, 2013). Upon mitochondrial damage, parkin is recruited to damaged mitochondria downstream of PINK1, which phosphorylates Ser65 on the ubiquitin-like (UBL) domain of parkin (Kondapalli et al, 2012;Shiba-Fukushima et al, 2012) and Ser65 on ubiquitin, leading to parkin activation (Kane et al, 2014;Kazlauskaite et al, 2014;Koyano et al, 2014;Ordureau et al, 2014;Zhang et al, 2014).…”
Section: Dynamics Of Mitochondrial Degradation In Neurodegenerative Dmentioning
confidence: 99%